Hengrui Medicine Co., Ltd. (600276.SH): -3 glyceride triglyceride (2%) medium/long chain fat emulsion/amino acid (16)/glucose (30%) injection approved for market listing.

Zhichong Finance and Economics APP news, Hengrui Medicine (600276.SH) announced that recently, the company's subsidiary, Fujian Shengdi Medicine Co., Ltd., received a notice from the National Medical Products Administration, approving the listing of the company's omega-3 glycerol triester (2%) medium/long chain fat emulsion/amino acid (16)/glucose (30%) injection.